Glaukos Corp. (GKOS)
185.81
+0.92
(+0.50%)
USD |
NYSE |
Aug 24, 16:00
185.81
0.00 (0.00%)
After-Hours: 19:56
Glaukos Enterprise Value : 10.70B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 10.70B |
| August 20, 2026 | 10.70B |
| August 19, 2026 | 10.97B |
| August 18, 2026 | 10.66B |
| August 17, 2026 | 10.74B |
| August 14, 2026 | 10.68B |
| August 13, 2026 | 10.97B |
| August 12, 2026 | 10.80B |
| August 11, 2026 | 10.53B |
| August 10, 2026 | 10.49B |
| August 07, 2026 | 10.41B |
| August 06, 2026 | 9.881B |
| August 05, 2026 | 9.877B |
| August 04, 2026 | 9.854B |
| August 03, 2026 | 9.874B |
| July 31, 2026 | 9.629B |
| July 30, 2026 | 9.735B |
| July 29, 2026 | 9.332B |
| July 28, 2026 | 8.724B |
| July 27, 2026 | 8.758B |
| July 24, 2026 | 8.856B |
| July 23, 2026 | 8.771B |
| July 22, 2026 | 8.814B |
| July 21, 2026 | 8.827B |
| July 20, 2026 | 8.967B |
| Date | Value |
|---|---|
| July 17, 2026 | 9.047B |
| July 16, 2026 | 8.963B |
| July 15, 2026 | 9.048B |
| July 14, 2026 | 8.790B |
| July 13, 2026 | 8.805B |
| July 10, 2026 | 8.805B |
| July 09, 2026 | 8.944B |
| July 08, 2026 | 8.820B |
| July 07, 2026 | 8.684B |
| July 06, 2026 | 8.569B |
| July 02, 2026 | 8.548B |
| July 01, 2026 | 7.914B |
| June 30, 2026 | 8.043B |
| June 29, 2026 | 8.124B |
| June 26, 2026 | 8.255B |
| June 25, 2026 | 8.147B |
| June 24, 2026 | 7.866B |
| June 23, 2026 | 7.684B |
| June 22, 2026 | 7.482B |
| June 18, 2026 | 7.453B |
| June 17, 2026 | 7.262B |
| June 16, 2026 | 7.269B |
| June 15, 2026 | 7.421B |
| June 12, 2026 | 7.227B |
| June 11, 2026 | 7.078B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 11.18B |
| Abbott Laboratories | 229.49B |
| Alphatec Holdings, Inc. | 1.956B |
| Artivion, Inc. | 1.698B |
| ICU Medical, Inc. | 5.561B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.38M |
| Revenue (Quarterly) | 185.61M |
| Total Expenses (Quarterly) | 203.99M |
| EPS Diluted (Quarterly) | -0.3124 |
| Gross Profit Margin (Quarterly) | 81.67% |
| Profit Margin (Quarterly) | -9.90% |
| Earnings Yield | -1.75% |
| Normalized Earnings Yield | -1.006 |